Inlyta 1 MG tablet 180S
Ended Awarded Last action
- Contract number
- SPE2DR26F9NS5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,131
Award facts
- Contract value 100% obligated
- $25,131.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order by the Defense Logistics Agency on January 30, 2026, for INLYTA (axitinib) 1 mg tablets in a quantity of 180 units, with a ceiling value of $25,131.26 and a firm fixed price structure. This competitively awarded contract with no set-aside designation is set to be completed by February 23, 2026, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. INLYTA is a targeted cancer therapy medication used primarily in the treatment of renal cell carcinoma and other advanced malignancies, reflecting the Defense Logistics Agency's ongoing need to supply specialized pharmaceutical products to military and veteran healthcare systems.
This delivery order represents a task order issued under Amerisourcebergen's substantial Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The parent company, Cencora, Inc., holds an even larger IDC with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, which serves as a comprehensive global pharmaceutical support vehicle enabling the supply of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide. These contract vehicles underscore Amerisourcebergen's critical role as a pharmaceutical prime vendor for federal defense health operations.
Quick answers
Who was awarded contract SPE2DR26F9NS5?
SPE2DR26F9NS5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F9NS5 worth?
The government has obligated $25,131 on SPE2DR26F9NS5.
Is contract SPE2DR26F9NS5 an order under another contract?
Yes. SPE2DR26F9NS5 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9NS5 competed?
The extent of competition for SPE2DR26F9NS5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award